| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 102,233 | 54,698 | 17,245 | | Cost of Revenue | 11,956 | 12,097 | 11,933 | | | Gross Profit | 90,277 | 42,601 | 5,312 | | | Operating Expenses | | Research Development | 76,996 | 26,681 | 13,316 | | Selling General and Administrative | 18,904 | 17,374 | 14,579 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,623) | (1,454) | (22,583) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,250) | 4,703 | 1,572 | | Earnings Before Interest And Taxes | (8,873) | 3,249 | (21,011) | | Interest Expense | 1,064 | 538 | 593 | | Income Before Tax | (9,937) | 2,711 | (21,604) | | Income Tax Expense | 3 | 5,095 | 20 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,940) | (2,384) | (21,624) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,940) | (2,384) | (21,624) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,940) | ($2,384) | ($21,624) |
|
0.29% Nasdaq 
Income Statement
